Real-world study reveals similar response distributions between baricitinib and ritlecitinib in severe alopecia areata, suggesting comparable clinical utility across both therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cedirian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: